Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission

Oren Pasvolsky, Rima M. Saliba, Celina Ledesma, Uday R. Popat, Amin Alousi, Amanda Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H. Qazilbash, Nicholas J. Short, Farhad Ravandi, Richard Champlin, Elizabeth J. Shpall, Partow Kebriaei*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalAmerican Journal of Hematology
DOIs
StateAccepted/In press - 2022

Cite this